
Nippon Shinyaku Co., Ltd. – OTC:NPPNY
Nippon Shinyaku Co., Ltd. stock price today
Nippon Shinyaku Co., Ltd. stock price monthly change
Nippon Shinyaku Co., Ltd. stock price quarterly change
Nippon Shinyaku Co., Ltd. stock price yearly change
Nippon Shinyaku Co., Ltd. key metrics
Market Cap | 3.42B |
Enterprise value | 196.84B |
P/E | 2.31 |
EV/Sales | 1.32 |
EV/EBITDA | 5.03 |
Price/Sales | 1.61 |
Price/Book | 0.27 |
PEG ratio | N/A |
EPS | 62.62 |
Revenue | 135.69B |
EBITDA | 18.57B |
Income | 10.41B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 17.44% |
Oper. margin | 22.76% |
Gross margin | 66.12% |
EBIT margin | 22.76% |
EBITDA margin | 13.69% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNippon Shinyaku Co., Ltd. stock price history
Nippon Shinyaku Co., Ltd. stock forecast
Nippon Shinyaku Co., Ltd. financial statements
Dec 2021 | 34.65B | 6.04B | 17.45% |
---|---|---|---|
Mar 2022 | 31.26B | 2.38B | 7.61% |
Mar 2023 | 34.25B | 138M | 0.4% |
Mar 2024 | 35.52B | 1.84B | 5.2% |
Payout ratio | 30.99% |
---|
2020 | 3.63% |
---|---|
2021 | 4.74% |
2022 | 4.9% |
2023 | 7.87% |
2024 | 10.17% |
Sep 2022 | 225374000000 | 33.87B | 15.03% |
---|---|---|---|
Dec 2022 | 231876000000 | 35.90B | 15.49% |
Mar 2023 | 237451000000 | 41.52B | 17.49% |
Mar 2024 | 263404000000 | 42.86B | 16.27% |
Dec 2021 | -4.21B | -1.59B | -4.42B |
---|---|---|---|
Mar 2022 | 12.19B | -6.49B | -617M |
Mar 2023 | 13.55B | -8.21B | -683M |
Mar 2024 | 8.16B | -7.26B | -673M |
Nippon Shinyaku Co., Ltd. alternative data
Aug 2023 | 2,186 |
---|---|
Sep 2023 | 2,186 |
Oct 2023 | 2,186 |
Nov 2023 | 2,186 |
Dec 2023 | 2,186 |
Jan 2024 | 2,186 |
Feb 2024 | 2,186 |
Mar 2024 | 2,186 |
Apr 2024 | 2,186 |
May 2024 | 2,186 |
Jun 2024 | 2,186 |
Jul 2024 | 2,186 |
Nippon Shinyaku Co., Ltd. other data
-
What's the price of Nippon Shinyaku Co., Ltd. stock today?
One share of Nippon Shinyaku Co., Ltd. stock can currently be purchased for approximately $5.37.
-
When is Nippon Shinyaku Co., Ltd.'s next earnings date?
Unfortunately, Nippon Shinyaku Co., Ltd.'s (NPPNY) next earnings date is currently unknown.
-
Does Nippon Shinyaku Co., Ltd. pay dividends?
Yes, Nippon Shinyaku Co., Ltd. pays dividends and its trailing 12-month yield is 0% with 31% payout ratio. The last Nippon Shinyaku Co., Ltd. stock dividend of undefined was paid on 1 Sep 2025.
-
How much money does Nippon Shinyaku Co., Ltd. make?
Nippon Shinyaku Co., Ltd. has a market capitalization of 3.42B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.83% to 148.26B US dollars.
-
What is Nippon Shinyaku Co., Ltd.'s stock symbol?
Nippon Shinyaku Co., Ltd. is traded on the OTC under the ticker symbol "NPPNY".
-
What is Nippon Shinyaku Co., Ltd.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Nippon Shinyaku Co., Ltd.?
Shares of Nippon Shinyaku Co., Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Nippon Shinyaku Co., Ltd. have?
As Jul 2024, Nippon Shinyaku Co., Ltd. employs 2,186 workers.
-
When Nippon Shinyaku Co., Ltd. went public?
Nippon Shinyaku Co., Ltd. is publicly traded company for more then 8 years since IPO on 16 Nov 2016.
-
What is Nippon Shinyaku Co., Ltd.'s official website?
The official website for Nippon Shinyaku Co., Ltd. is nippon-shinyaku.co.jp.
-
How can i contact Nippon Shinyaku Co., Ltd.?
Nippon Shinyaku Co., Ltd. can be reached via phone at +81 75 321 1111.
Nippon Shinyaku Co., Ltd. company profile:

Nippon Shinyaku Co., Ltd.
nippon-shinyaku.co.jpOTC
2,125
Drug Manufacturers—Specialty & Generic
Healthcare
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, otorhinolaryngology, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, and sports and aging care supplements. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
Kyoto, 601-8550
:
ISIN: US65461U1088
: